{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:20:38Z","timestamp":1790806838185,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.clon.2022.05.021","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:53:58Z","timestamp":1655254438000},"page":"e392-e399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Surgical Treatments of Benign Prostatic Hyperplasia and Prostate Cancer Stereotactic Radiotherapy: Impact on Long-Term Genitourinary Toxicity"],"prefix":"10.1016","volume":"34","author":[{"given":"C.","family":"Huck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Achard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Zilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2022.05.021_bib1","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.ijrobp.2019.03.051","article-title":"Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies","volume":"104","author":"Jackson","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2022.05.021_bib2","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.clon.2021.12.006","article-title":"Ultrahypofractionated radiotherapy for localised prostate cancer: how far can we go?","volume":"34","author":"Corkum","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2022.05.021_bib3","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0140-6736(19)31131-6","article-title":"Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial","volume":"394","author":"Widmark","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2022.05.021_bib4","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S1470-2045(19)30569-8","article-title":"Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial","volume":"20","author":"Brand","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2022.05.021_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ajur.2017.11.008","article-title":"Laparoscopic adenomectomy in BPH \u2013 does it have a role today?","volume":"5","author":"Manickam","year":"2018","journal-title":"Asian J Urol"},{"key":"10.1016\/j.clon.2022.05.021_bib6","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ijrobp.2009.06.078","article-title":"External beam radiation therapy after transurethral resection of the prostate: a report on acute and late genitourinary toxicity","volume":"77","author":"Devisetty","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2022.05.021_bib7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0360-3016(00)00714-8","article-title":"Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection","volume":"48","author":"Sandhu","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2022.05.021_bib8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13014-018-1059-1","article-title":"Urethra-sparing stereotactic body radiotherapy for prostate cancer: how much can the rectal wall dose be reduced with or without an endorectal balloon?","volume":"13","author":"Dubouloz","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clon.2022.05.021_bib9","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1002\/cam4.2966","article-title":"Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results","volume":"9","author":"Zilli","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.clon.2022.05.021_bib10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.urology.2018.12.031","article-title":"Endoscopic transvesical adenomectomy of the prostate, a new minimal invasive approach for large benign prostate hyperplasia. A description of the technique and the results of the first 40 patients","volume":"125","author":"van der Sanden","year":"2019","journal-title":"Urology"},{"key":"10.1016\/j.clon.2022.05.021_bib11","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.eururo.2005.12.042","article-title":"Complications of transurethral resection of the prostate (TURP) \u2013 incidence, management, and prevention","volume":"50","author":"Rassweiler","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.clon.2022.05.021_bib12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/COC.0b013e3182546821","article-title":"Is there an increase in genitourinary toxicity in patients treated with transurethral resection of the prostate and radiotherapy? A systematic review","volume":"37","author":"Ishiyama","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clon.2022.05.021_bib13","first-page":"43","article-title":"Experimental studies of regeneration of the ureter without intubation","volume":"75","author":"Hamm","year":"1956","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.clon.2022.05.021_bib14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/bjc.1982.217","article-title":"Early and late morphological changes (including carcinoma of the urothelium) induced by irradiation of the rat urinary bladder","volume":"46","author":"Antonakopoulos","year":"1982","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2022.05.021_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/path.1711430205","article-title":"The subcellular basis of damage to the human urinary bladder induced by irradiation","volume":"143","author":"Antonakopoulos","year":"1984","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.clon.2022.05.021_bib16","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0360-3016(94)00431-J","article-title":"The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy","volume":"31","author":"Marks","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2022.05.021_bib17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13014-015-0351-6","article-title":"Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer","volume":"10","author":"Gurka","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clon.2022.05.021_bib18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.prro.2019.04.003","article-title":"Safety of prostate stereotactic body radiation therapy after transurethral resection of prostate (TURP): a propensity score matched pair analysis","volume":"9","author":"Murthy","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.clon.2022.05.021_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3389\/fonc.2020.00555","article-title":"Urinary morbidity in men treated with stereotactic body radiation therapy (SBRT) for localized prostate cancer following transurethral resection of the prostate (TURP)","volume":"10","author":"Pepin","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.clon.2022.05.021_bib20","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/0360-3016(86)90283-X","article-title":"The effect of prior transurethral resection of the prostate on post radiation urethral strictures and bladder neck contractures","volume":"12","author":"Seymore","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2022.05.021_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13014-018-1149-0","article-title":"Urinary function and quality of life after radiotherapy for prostate cancer in patients with prior history of surgical treatment for benign prostatic hyperplasia","volume":"13","author":"Guilhen","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clon.2022.05.021_bib22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijrobp.2022.01.022","article-title":"Intraprostatic urethra: the new kid on the block for prostate cancer radiation therapy?","volume":"113","author":"Zilli","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2022.05.021_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijrobp.2021.06.037","article-title":"Radiation dose to the intraprostatic urethra correlates strongly with urinary toxicity after prostate stereotactic body radiation therapy: a combined analysis of 23 prospective clinical trials","volume":"112","author":"Leeman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2022.05.021_bib24","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1016\/j.ijrobp.2011.02.037","article-title":"Urethra-sparing, intraoperative, real-time planned, permanent-seed prostate brachytherapy: toxicity analysis","volume":"81","author":"Zilli","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2022.05.021_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0167-8140(00)00306-6","article-title":"ESTRO\/EAU\/EORTC recommendations on permanent seed implantation for localized prostate cancer","volume":"57","author":"Ash","year":"2000","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2022.05.021_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5114\/jcb.2020.92913","article-title":"A\u00a0history of transurethral resection of the prostate should not be a contra-indication for low-dose-rate (125)I prostate brachytherapy: results of a prospective Uro-GEC phase-II trial","volume":"12","author":"Salembier","year":"2020","journal-title":"J\u00a0Contemp Brachyther"},{"key":"10.1016\/j.clon.2022.05.021_bib27","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fonc.2016.00122","article-title":"Acute urinary morbidity following stereotactic body radiation therapy for prostate cancer with prophylactic alpha-adrenergic antagonist and urethral dose reduction","volume":"6","author":"Repka","year":"2016","journal-title":"Front Oncol"},{"key":"10.1016\/j.clon.2022.05.021_bib28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0002-9610(05)81019-0","article-title":"Relationship of oxygen dose to angiogenesis induction in irradiated tissue","volume":"160","author":"Marx","year":"1990","journal-title":"Am J Surg"},{"key":"10.1016\/j.clon.2022.05.021_bib29","first-page":"Cd005005","article-title":"Hyperbaric oxygen therapy for late radiation tissue injury","volume":"4","author":"Bennett","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clon.2022.05.021_bib30","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(95)91620-2","article-title":"Hyperbaric oxygen treatment for haemorrhagic radiation cystitis","volume":"346","author":"Bevers","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2022.05.021_bib31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ijrobp.2013.07.039","article-title":"Hyperbaric oxygen treatment in radiation-induced cystitis and proctitis: a prospective cohort study on patient-perceived quality of recovery","volume":"87","author":"Oscarsson","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2022.05.021_bib32","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ijrobp.2011.12.056","article-title":"Hyperbaric oxygen therapy for radiation-induced cystitis and proctitis","volume":"84","author":"Oliai","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2022.05.021_bib33","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/S1470-2045(19)30494-2","article-title":"Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2\u20133 trial","volume":"20","author":"Oscarsson","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2022.05.021_bib34","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jvir.2021.03.534","article-title":"Effectiveness and safety of prostatic artery embolization for the treatment of lower urinary tract symptoms from benign prostatic hyperplasia in men with concurrent localized prostate cancer","volume":"32","author":"Parikh","year":"2021","journal-title":"J\u00a0Vasc Interv Radiol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655522002722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655522002722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:51:49Z","timestamp":1760543509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655522002722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0936655522002722"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2022.05.021","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical Treatments of Benign Prostatic Hyperplasia and Prostate Cancer Stereotactic Radiotherapy: Impact on Long-Term Genitourinary Toxicity","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2022.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}]}}